2Durie BG, Kyle RA, Belch A, et al. Myeloma management guidelines:a consensus report from the Scientific Advisors of the International Myeloma Foundation[J]. Hematol, 2003, 4(6): 379-398.
3Blade J, Samson D, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant[J]. Br J Haematol. 1998.102(5):1115-1123.
4Damaj G, Mohty M, Vey N, et al. Features of extramedullary and extraosseous multiple myeloma:a report of 19 patients from a single center[J]. Eur J Haematol, 2004, 73(6): 402-406.
5Garcia-Sanz R, Orfao A, Gonzalez M, et al. Primary plasma cell leukemia: clinical, immunophenotypic, DAN ploidy and cytogenetic characteristics[J]. Blood, 1999, 93(3): 1032-1037.
6Dimopoulos MA, Palumbo A, Delasalle KB, et al. Primary plasma cell leukemia[J]. Br J Haematol, 1994-, 88(4): 754-759.
